Stryker CEO Kevin Lobo says robots now do 2 of every 3 knee replacements—and he won’t build them in China because ‘the IP is a massive worry’
Kevin Lobo told Fortune that Chinese companies are “knocking off a lot of the other robots” as Stryker bets $400 million on a soft-tissue surgical robot.
Full story
Read the full story at Fortune ↗
Continue reading this story on Fortune, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.